BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17613764)

  • 1. Characterization of genetic changes in MCL by interphase FISH on tissue sections.
    Sander B; Wallblom A; Ekroth A; Porwit A; Kimby E
    Leuk Lymphoma; 2007 Jul; 48(7):1344-52. PubMed ID: 17613764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
    Greiner TC; Dasgupta C; Ho VV; Weisenburger DD; Smith LM; Lynch JC; Vose JM; Fu K; Armitage JO; Braziel RM; Campo E; Delabie J; Gascoyne RD; Jaffe ES; Muller-Hermelink HK; Ott G; Rosenwald A; Staudt LM; Im MY; Karaman MW; Pike BL; Chan WC; Hacia JG
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2352-7. PubMed ID: 16461462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ATM gene in the pathogenesis of mantle-cell lymphoma.
    Stilgenbauer S; Schaffner C; Winkler D; Ott G; Leupolt E; Bentz M; Möller P; Müller-Hermelink HK; James MR; Lichter P; Döhner H
    Ann Oncol; 2000; 11 Suppl 1():127-30. PubMed ID: 10707794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.
    Rosenwald A; Wright G; Wiestner A; Chan WC; Connors JM; Campo E; Gascoyne RD; Grogan TM; Muller-Hermelink HK; Smeland EB; Chiorazzi M; Giltnane JM; Hurt EM; Zhao H; Averett L; Henrickson S; Yang L; Powell J; Wilson WH; Jaffe ES; Simon R; Klausner RD; Montserrat E; Bosch F; Greiner TC; Weisenburger DD; Sanger WG; Dave BJ; Lynch JC; Vose J; Armitage JO; Fisher RI; Miller TP; LeBlanc M; Ott G; Kvaloy S; Holte H; Delabie J; Staudt LM
    Cancer Cell; 2003 Feb; 3(2):185-97. PubMed ID: 12620412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index.
    Slotta-Huspenina J; Koch I; de Leval L; Keller G; Klier M; Bink K; Kremer M; Raffeld M; Fend F; Quintanilla-Martinez L
    Haematologica; 2012 Sep; 97(9):1422-30. PubMed ID: 22315488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis.
    Katzenberger T; Kienle D; Stilgenbauer S; Höller S; Schilling C; Mäder U; Puppe B; Petzoldt C; Sander S; Bullinger L; Stöcklein H; Kalla J; Hartmann E; Adam P; Ott MM; Müller-Hermelink HK; Rosenwald A; Ott G
    Br J Haematol; 2008 Aug; 142(4):538-50. PubMed ID: 18564361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.
    Parrens M; Belaud-Rotureau MA; Fitoussi O; Carerre N; Bouabdallah K; Marit G; Dubus P; de Mascarel A; Merlio JP
    Histopathology; 2006 Mar; 48(4):353-62. PubMed ID: 16487357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry.
    Hui P; Howe JG; Crouch J; Nimmakayalu M; Qumsiyeh MB; Tallini G; Flynn SD; Smith BR
    Leuk Lymphoma; 2003 Aug; 44(8):1385-94. PubMed ID: 12952233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma.
    M'kacher R; Bennaceur A; Farace F; Laugé A; Plassa LF; Wittmer E; Dossou J; Violot D; Deutsch E; Bourhis J; Stoppa-Lyonnet D; Ribrag V; Carde P; Parmentier C; Bernheim A; Turhan AG
    Oncogene; 2003 Sep; 22(39):7905-12. PubMed ID: 12970738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid detection of the t(11;14) translocation in mantle cell lymphoma by interphase fluorescence in situ hybridization on archival cytopathologic material.
    Bentz JS; Rowe LR; Anderson SR; Gupta PK; McGrath CM
    Cancer; 2004 Apr; 102(2):124-31. PubMed ID: 15098257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome.
    Michaux L; Wlodarska I; Theate I; Stul M; Scheiff JM; Deneys V; Ferrant A; Hagemeijer A
    Ann Hematol; 2004 Sep; 83(9):578-83. PubMed ID: 15138714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas.
    Belaud-Rotureau MA; Parrens M; Dubus P; Garroste JC; de Mascarel A; Merlio JP
    Mod Pathol; 2002 May; 15(5):517-25. PubMed ID: 12011256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
    Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
    Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mantle cell lymphoma is characterized by inactivation of the ATM gene.
    Schaffner C; Idler I; Stilgenbauer S; Döhner H; Lichter P
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2773-8. PubMed ID: 10706620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mantle Cell Lymphoma With MYC Rearrangement: A Report of 17 Patients.
    Hu Z; Medeiros LJ; Chen Z; Chen W; Li S; Konoplev SN; Lu X; Pham LV; Young KH; Wang W; Hu S
    Am J Surg Pathol; 2017 Feb; 41(2):216-224. PubMed ID: 27776009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial lymphoid neoplasms in patients with mantle cell lymphoma.
    Tort F; Camacho E; Bosch F; Harris NL; Montserrat E; Campo E
    Haematologica; 2004 Mar; 89(3):314-9. PubMed ID: 15020270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1.
    Sander B; Flygare J; Porwit-Macdonald A; Smith CI; Emanuelsson E; Kimby E; Liden J; Christensson B
    Int J Cancer; 2005 Nov; 117(3):418-30. PubMed ID: 15900590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma.
    Choe JY; Yun JY; Na HY; Huh J; Shin SJ; Kim HJ; Paik JH; Kim YA; Nam SJ; Jeon YK; Park G; Kim JE
    Histopathology; 2016 Feb; 68(3):442-9. PubMed ID: 26100211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of 4 mantle cell lymphoma cell lines.
    Amin HM; McDonnell TJ; Medeiros LJ; Rassidakis GZ; Leventaki V; O'Connor SL; Keating MJ; Lai R
    Arch Pathol Lab Med; 2003 Apr; 127(4):424-31. PubMed ID: 12683869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive FISH testing using FFPE tissue microarray of primary lymph node tissue identifies secondary cytogenetic abnormalities in Mantle Cell Lymphoma.
    Webb F; Morey A; Mahler-Hinder C; Georgousopoulou E; Koo R; Pati N; Talaulikar D
    Cancer Genet; 2023 Jun; 274-275():75-83. PubMed ID: 37094546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.